Anti-vascular endothelial growth factor for neovascular glaucoma.

Simha, Arathi; Aziz, Kanza; Braganza, Andrew; Abraham, Lekha; Samuel, Prasanna; Lindsley, Kristina B

Simha, Arathi; Aziz, Kanza; Braganza, Andrew; Abraham, Lekha; Samuel, Prasanna; Lindsley, Kristina B.

Affiliation

Simha A; Christian Medical College, Department of Ophthalmology, Vellore, India, 632001.
Aziz K; Johns Hopkins University School of Medicine, Wilmer Eye Institute, Baltimore, Maryland, USA, 21287.
Braganza A; Christian Medical College, Department of Ophthalmology, Vellore, India, 632001.
Abraham L; Christian Medical College, Department of Ophthalmology, Vellore, India, 632001.
Samuel P; Christian Medical College, Department of Biostatistics, Vellore, Tamil Nadu, India, 632002.
Lindsley KB; IBM Watson Health, Life Sciences, Oncology, & Genomics, Baltimore, Maryland, USA.

Cochrane Database Syst Rev ; 2: CD007920, 2020 02 06.

Article in En | MEDLINE | ID: mdl-32027392

Subject(s)

Glaucoma, Neovascular/drug therapy; Intraocular Pressure/drug effects; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Endothelial Growth Factors; Humans; Randomized Controlled Trials as Topic; Visual Acuity/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glaucoma, Neovascular / Vascular Endothelial Growth Factor A / Intraocular Pressure Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Cochrane Database Syst Rev Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google